Marché des isolateurs pharmaceutiques – Analyse des tendances et de la croissance | Année de prévision 2031

  • Report Code : TIPRE00023786
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 202
Buy Now

Le marché des isolateurs pharmaceutiques était évalué à 5 966,07 millions de dollars américains en 2021, il devrait croître à un TCAC de 8,5 % de 2021 à 2028.



L'isolateur pharmaceutique est une enceinte scellée bactériologiquement utilisée dans l'environnement médical et pharmaceutique pour les procédés toxiques et les procédés de remplissage aseptique. Il comprend également des systèmes de transfert qui permettent l'entrée et la sortie des produits et l'élimination des déchets sans rompre les conditions aseptiques.





La portée du marché des isolateurs pharmaceutiques comprend le type, la pression, la configuration, l'application, l'utilisateur final et la région. Le marché des isolateurs pharmaceutiques est analysé en fonction de régions telles que l'Amérique du Nord, l'Europe, l'Asie-Pacifique, le Moyen-Orient et l'Afrique et l'Amérique du Sud et centrale. Le rapport offre des informations et une analyse approfondie du marché des isolateurs pharmaceutiques, en mettant l'accent sur divers paramètres tels que les tendances du marché, les progrès technologiques, la dynamique du marché et l'analyse du paysage concurrentiel des principaux acteurs du marché à travers le monde.



Régions lucratives pour le marché des isolateurs pharmaceutiques

Aperçu du marché



Cadre réglementaire pour soutenir l'adoption des isolateurs pharmaceutiques



Un isolateur pharmaceutique offre une qualité supérieure environnement stérile que les salles blanches conventionnelles. Des pressions positives ou négatives à l'intérieur de la chambre empêchent la contamination due à l'interférence de l'opérateur. Il assure une stérilité durable conformément à la réglementation pharmaceutique liée à la fabrication de produits médicaux stériles. De plus, la plupart des experts s'accordent à dire que les agences de réglementation n'entravent plus les progrès en matière de technologies telles que les isolateurs pharmaceutiques. Les directives établies par la Food and Drug Administration des États-Unis (US FDA) et l'Agence européenne des médicaments concernant les isolateurs jouent un rôle important dans l'adoption des isolateurs par rapport aux salles blanches. La FDA mentionne les isolateurs 55 fois dans sa dernière directive de fabrication dans un environnement aseptique. Un isolateur à pression positive bien conçu, soutenu par des procédures adéquates pour sa maintenance, sa surveillance et ses contrôles, offre des avantages significatifs par rapport au traitement aseptique traditionnel, notamment moins de possibilités de contamination microbienne pendant le traitement. De plus, la FDA reconnaît la suppression des opérateurs dans les domaines critiques de la fabrication pharmaceutique, ce qui devrait propulser l'adoption d'isolateurs pharmaceutiques dans les années à venir. L'analyse des tendances montre un nombre croissant d'établissements pharmaceutiques utilisant la technologie des isolateurs aux États-Unis. En 1998, seules 84 installations étaient équipées de remplissage aseptique en isolateurs. Ce nombre est passé à 174 installations en 2000, 201 en 2002 et 258 en 2004. La croissance du nombre d'installations offrant un traitement aseptique est liée à la croissance de la production de médicaments à forte puissance.



Type -Based Insights



En fonction du type, le marché des isolateurs pharmaceutiques est segmenté en isolateur ouvert et isolateur fermé. Le segment des isolateurs ouverts détenait une plus grande part du marché, et le même segment devrait enregistrer un TCAC plus élevé sur le marché au cours de la période de prévision.



Informations basées sur la pression



Basé sur la pression, le marché des isolateurs pharmaceutiques est segmenté en pression positive et pression négative. En 2021, le segment de la pression positive détenait une part de marché plus importante ; cependant, le segment de pression négative devrait croître au rythme le plus rapide au cours de la période de prévision. La croissance du segment de la pression positive est attribuée à ses avantages tels qu'une protection avancée des produits et une adoption plus élevée dans la préparation de médicaments stériles.



Marché mondial des isolateurs pharmaceutiques, par pression - 2021 et 2028

Insights stratégiques



Insights basés sur la configuration



Selon la configuration, le Le marché des isolateurs pharmaceutiques est segmenté en debout, modulaire, mobile, compact, de table et portable. Le segment au sol est susceptible de détenir la plus grande part du marché, et le même segment devrait enregistrer le TCAC le plus élevé du marché au cours de la période de prévision. La croissance du segment au sol est attribuée à une efficacité améliorée, associée à des opérations plus rapides.



Informations basées sur les applications



En fonction de l'application, le marché des isolateurs pharmaceutiques est segmenté en isolateurs aseptiques, isolateurs de confinement, isolateurs d'échantillonnage et de pesage, isolateurs de distribution de fluides et autres. Le segment des isolateurs aseptiques devrait détenir la plus grande part du marché. En outre, le même segment devrait enregistrer le TCAC le plus élevé du marché au cours de la période de prévision.



Informations basées sur l'utilisateur final



En fonction de l'utilisateur final, le marché des isolateurs pharmaceutiques est segmenté en hôpitaux, sociétés pharmaceutiques et biotechnologiques, laboratoires de recherche et universitaires, etc. Le segment des sociétés pharmaceutiques et biotechnologiques devrait détenir la plus grande part du marché, et le même segment devrait enregistrer le TCAC le plus élevé du marché au cours de la période de prévision.



La pandémie de COVID-19 est devenue le défi le plus important à travers le monde. Il a perturbé divers métiers et entreprises à travers le monde. Cependant, la pandémie a apporté plusieurs opportunités de croissance aux entreprises pharmaceutiques et biopharmaceutiques pour renforcer leur recherche et développement de vaccins innovants contre le nouveau coronavirus. Les entreprises effectuent des essais cliniques pour freiner la propagation du virus COVID-19. Ainsi, l'augmentation des essais cliniques conduira à des opportunités vitales pour les fournisseurs d'isolateurs pharmaceutiques pour les sociétés biopharmaceutiques.



L'acquisition, la collaboration, les partenariats, les lancements de nouveaux produits et les stratégies d'expansion sont couramment adoptés par les entreprises pour étendre leur empreinte dans le monde entier et répondre à la demande croissante.



Les acteurs du marché opérant sur le marché des isolateurs pharmaceutiques ont adopté la stratégie d'innovation produit pour répondre à l'évolution de la demande des clients à travers le monde, ce qui aide également les acteurs à maintenir leur marque à l'échelle mondiale.



Profils d'entreprises




  • ITECO srl

  • Schematic Engineering Industries

  • Nuaire Inc.

  • Comecer < /li>
  • Getinge AB

  • Hosokawa Micron Group

  • Fedegari Autoclavi SpA

  • Azbil Telstar

  • Gelman Singapour

  • Bioquell (Solution Ecolab)


Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is Pharmaceutical isolator?

The pharmaceutical isolator is a bacteriologically sealed enclosure used in the medical and pharmaceutical environment for toxic processes and aseptic filling process. It also includes transfer systems that allow the entry and exit of the products and the elimination of waste without breaking aseptic conditions.

What are the driving factors for the Pharmaceutical isolator market across the globe?

The factors that are driving growth of the market are increase in investments by pharmaceutical and biotechnology industry, and regulatory framework to support adoption of pharmaceutical isolators are expected to boost the growth of the global Pharmaceutical isolator market.

What are the challenges hindering the adoption of Pharmaceutical Isolator?

The factors that are restraining the adoption of pharmaceutical isolator are high cost involved in operation and maintenance of pharmaceutical isolators.

Who are the major players in the pharmaceutical isolator market?

The pharmaceutical isolator market majorly consists of the players such as ITECO S.R.L., Schematic Engineering Industries, Nuaire Inc., Comecer, Getinge AB, Hosokawa Micron Group, Fedegari Autoclavi S.p.A., Azbil Telstar, Gelman Singapore, Bioquell (Ecolab Solution) and among others.

What are the growth strategies being implemented by major market players?

The market players are involved in acquisitions, strategic collaborations, and new product launches to withstand the competition. For instance, in June 2021, Comecer partners with G-CON o speed up the implementation of Cell & Gene Therapy cGMP manufacturing facility. G-CON’s new Aseptic facility integrate Comecer’s upstream processing & downstream filling technologies for turnkey aseptic facility solutions including isolation technologies.

Which region accounted for the largest pharmaceutical isolator market share?

North America dominated the pharmaceutical isolator market with a share of 42% in 2020. This is attributable to increase in investments by pharmaceutical and biotechnology industry, the presence of advanced infrastructure, and regulatory framework supporting adoption of pharmaceutical isolators.

The List of Companies - Pharmaceutical Isolator Market

  1. ITECO S.R.L.      
  2. Schematic Engineering Industries   
  3. Nuaire Inc.           
  4. Comecer             
  5. Getinge AB          
  6. Hosokawa Micron Group              
  7. Fedegari Autoclavi S.p.A.             
  8. Azbil Telstar        
  9. Gelman Singapore           
  10. Bioquell (Ecolab Solution)

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports